CBUS
Biotechnology · Healthcare
CEO
Equibles does not estimate personal net worth.
Get an email with a short summary when Cibus, Inc. publishes a filing, an earnings call transcript or a press release.
Get CBUS alertsMichael Carr is recorded as CEO at Cibus, Inc. (CBUS). The proxy statement of Cibus, Inc. reports total compensation of $1,162,641 for Michael Carr in fiscal 2023, including a base salary of $208,334. Disclosed compensation is on record for 2 fiscal years. Michael Carr has spoken on 3 earnings calls across 1 company, most recently for Cibus, Inc. on November 3, 2022. Cibus, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cibus, Inc. includes Craig Wichner (CEO and Board Member), Peter Beetham (CEO, COO and Board Member), Rory Riggs (Chairman and Board Member) and 7 others.
“Thank you, Bill, and thank you for joining us on Calyxt's financial results and corporate update call today. Today, I would like to walk you through our progress over the past few months before turning the call over to Bill for a financial update.”
“Thank you, Bill, and thank you for joining us on Calyxt earnings and corporate update call today.”
“For those of you who may be getting up to speed with our story following our October 2021 announcement in which we repositioned Calyxt, I will take this moment to remind you we are a plant-based synthetic biology company committed to bringing the biomanufacturing capabilities of plants to innovative companies within…”
CBUS
Biotechnology · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Cibus, Inc. (CBUS) | Former President and Chief Executive Officer | $208,334 | $1,162,641 |
| 2022 | Cibus, Inc. (CBUS) | Former President and Chief Executive Officer | $500,000 | $1,514,006 |